跳至主要内容
临床试验/NL-OMON21680
NL-OMON21680尚未招募不适用

Dose individualization of Beta-lactam and fluoroquinolone antibiotics in ICU patients: to TDM or not to TDM and the effects on Outcome

Erasmus MC0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Erasmus MC
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ≥18 years of age
  • - Receiving intravenous antibiotic therapy of the target drugs

排除标准

  • - Pregnancy
  • - Patient already enrolled in this trial

研究者

发起方
Erasmus MC

相似试验

进行中(未招募)
1 期
Dose individualization of beta-lactam and fluoroquinolone antibiotics in intensive care unit patientsICU patients with infection
EUCTR2017-004677-14-NLErasmus MC250
招募中
不适用
Does guideline-based dosing of beta lactam antibiotics and vancomycin achieve the target drug concentrations more than therapeutic drug monitoring-based dosing in critically ill patients? (GUIDE TRIAL)Sepsis
ACTRN12619000693123Paul Williams150
进行中(未招募)
不适用
optimization of doses of broad spectrum B-lactames (ceftazidim and meropenem) and vancomycin in septic patient traeted with chronic hemodialysis.hemodialysisoligoanuriasepsisMedDRA version: 14.0Level: HLTClassification code 10040054Term: Sepsis, bacteraemia, viraemia and fungaemia NECSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: LLTClassification code 10066622Term: Chronic hemodialysisSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2011-001573-10-BEHôpital Erasme
进行中(未招募)
1 期
Pharmacokinetics of small spectcrum beta-lactam antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) on intensive care.Patients who are hospitalised on the Intensive Care Unit, and who are treated with Amoxicillin/Clavulanic acid or Cefuroxime, because of an infection.MedDRA version: 14.1Level: LLTClassification code 10053349Term: Pharmacokinetic studySystem Organ Class: 10022891 - Investigations
EUCTR2011-006107-35-BEGhent University Hospital37
尚未招募
不适用
Continuous vs. intermittent beta-lactam dosing in critically ill patients with sepsis: A randomized controlled trial.Sepsis
PACTR202009811610400Applied for and awaiting approval408